[ad_1] Thank you so much Drs. Nguyen and Do for your kind invitation to participate in 2020 Sonoma Eye – Third Session on January 30 2020! Please join us at https://t.co/GAdGJ5Y1Br https://t.co/mGrUaE5t8j [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Just published: Even in common disorders such as diabetic macular edema, macular anatomy, often used for treatment decisions & clinical trial endpoints, has limited correlation to visual acuity. #eyes #retina #diabetes #clinicalresearch #biotech #medicine https://t.co/mVTtQ4N1N1 [ad_2] Source by Thomas Ciulla, MD, MBA Return to …

[ad_1] Just published: Precision medicine is predicated on genetic testing. However, barriers of cost, complexity, and unfamiliarity with genetic testing illustrate unmet need. Educational efforts are underway. #eyes #retina #gene #genetics #genetherapy https://t.co/IAI8Lh5bi7 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potentially important pathway for treatment of common causes of v… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #ma… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health residents interested in #research. Congrats to this fantastic IU… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #macular edema to #AMD to #diabeticretinopathy to choroidal melanoma, an understanding of #suprachoroidal drug delivery becomes essential… https://t.co/4qIjnVZ9RP [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.